Olmesartan Mylan (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olmesartan Mylan, is an angiotensin II receptor blocker presented as a oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Olmesartan Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan Mylan is manufactured under strict quality standards and distributed globally by GNH USA to support cardiovascular care.

Olmesartan Mylan is an antihypertensive agent that works within the renin‑angiotensin system to lower elevated blood pressure. - Hypertension: helps lower systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure (adjunct): may be used with other agents to improve symptom control and outcomes. - Diabetic nephropathy (adjunct): used to slow the progression of kidney damage associated with diabetes.

The most         ... 

---      ...